ロード中...

Clinical Outlook for Type-1 and FOXP3(+) T Regulatory Cell-Based Therapy

T regulatory cells (Tregs) are subsets of T lymphocytes specialized in modulating antigen-specific immune responses in vivo. Hence, Tregs represent an ideal therapeutic tool to control detrimental immune reactions. Based on solid pre-clinical results, investigators started testing the safety and eff...

詳細記述

保存先:
書誌詳細
出版年:Front Immunol
主要な著者: Gregori, Silvia, Passerini, Laura, Roncarolo, Maria-Grazia
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2015
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4658444/
https://ncbi.nlm.nih.gov/pubmed/26635807
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2015.00593
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!